Dr. Sattar Gojraty, MD

Dr. Gojraty practices at Cleveland Clinic Martin North Hospital in Stuart, Florida, part of The Cleveland Clinic Foundation.

Dr. Gojraty's NPI, 1891957445, was assigned on June 25, 2008. Dr. Gojraty graduated from Perelman School of Medicine - Philadelphia in 2008. Dr. Gojraty holds Florida license ME119373.

Dr. Gojraty's primary practice is Cleveland Clinic Martin North Hospital, at 200 SE Hospital Ave, Stuart, FL 34994 in Martin County. The practice phone is (772) 287-5200.

Dr. Gojraty's primary practice is Cleveland Clinic Martin North Hospital in Stuart, Florida, part of The Cleveland Clinic Foundation. Dr. Gojraty is also affiliated with Jupiter Medical Center. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Gojraty to 1 more hospital, 3 group practices and clinics, 2 medical groups and 1 home health agency, each named with a free account. Dr. Gojraty's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gojraty practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Gojraty's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Gojraty is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Gojraty's licenses on file in 3 states: Florida, New York and Pennsylvania.

Dmand AI lists aneurysm, angioplasty, arterial blot clot /embolism, atrial fibrillation and flutter, cerebrovascular disease, chronic hypertension, coronary artery disease and heart blockage among the conditions Dr. Gojraty treats.

CMS data shows 14,264 Medicare services from Dr. Gojraty across 37 procedure codes in 2024, for 4,950 Medicare patients. Medicare paid $719,549 for them.

CMS counts 4,950 Medicare patients who saw Dr. Gojraty in 2024. The largest group is 75 to 84, with 2,108 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gojraty's median patient age at 68, with 52% women.

In 2024, Dr. Gojraty wrote 8,727 Medicare Part D claims for 1,313 patients. 83% of them were for generic drugs. CMS names the drug for 8,479 of them, across 71 drugs with 11 or more claims each, at $1,642,549 in total drug cost. In 2023, CMS named 7,598 claims across 65 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Gojraty for performance year 2024, reported individually. Dr. Gojraty accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Gojraty, published from 2008 to 2011. 2008 was the busiest year, with 2. The most frequent topics are Atrial Fibrillation, Body Surface Potential Mapping and Catheter Ablation. Dr. Gojraty has published most often in J Cardiovasc Electrophysiol. Dr. Gojraty's most frequent co-authors are Rupa Bala, MD, Mathew D. Hutchinson, MD and Christopher F. Liu, MD.

CMS Open Payments shows 45 general payments to Dr. Gojraty from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Abbott Laboratories paid the most, $265.

Dr. Gojraty graduated from Perelman School of Medicine - Philadelphia in 2008.

Dr. Gojraty is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.